Metabolic Dysfunction-associated Steatotic Liver Disease and Heart Failure with Preserved Ejection Fraction: a bidirectional relationship with clinical and therapeutic …
AR Leite, J Dias, T Godinho, J Correia-Chaves… - Endocrinology …, 2024 - karger.com
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is
increasingly prevalent and is the most common cause of chronic liver disease in the western …
increasingly prevalent and is the most common cause of chronic liver disease in the western …
Non-alcoholic fatty liver disease and risk of cardiovascular diseases: clinical association, pathophysiological mechanisms, and management
R Yang, JG Fan - Cardiology Plus, 2023 - journals.lww.com
Non-alcoholic fatty liver disease (NAFLD) is a fatty liver disease associated with metabolic
dysfunction in genetically susceptible individuals due to over-nutrition and lack of exercise …
dysfunction in genetically susceptible individuals due to over-nutrition and lack of exercise …
Clinical utility of the Fibrosis-4 index for predicting mortality in patients with heart failure with or without metabolic dysfunction-associated steatotic liver disease: a …
J Boeckmans, JH Prochaska, A Gieswinkel… - The Lancet Regional …, 2025 - thelancet.com
Background The liver–heart axis potentially influences the risk of mortality in patients with
heart failure. We aimed to identify the clinical utility of the fibrosis-4 (FIB-4) index in patients …
heart failure. We aimed to identify the clinical utility of the fibrosis-4 (FIB-4) index in patients …
[HTML][HTML] The Cardiac-Kidney-Liver (CKL) syndrome: the “real entity” of type 2 diabetes mellitus
N Katsiki, G Kolovou, A Melidonis… - Archives of Medical …, 2024 - ncbi.nlm.nih.gov
Almost 7 years ago, the 2018 ADA/EASD guidelines shifted the management of type 2
diabetes mellitus (T2DM) from a “glucocentric” to a “cardiorenal” approach based on the …
diabetes mellitus (T2DM) from a “glucocentric” to a “cardiorenal” approach based on the …
[HTML][HTML] Cardiac Abnormalities Pre-and Post-Liver Transplantation for Metabolic Dysfunction-Associated Steatohepatitis–Evidence and Special Considerations
SM Elzein, EW Brombosz, S Kodali - Journal of Liver Transplantation, 2024 - Elsevier
Metabolic dysfunction-associated steatotic liver disease (MASLD) has an alarmingly high
global prevalence. Its progressive subtype, metabolic dysfunction-associated steatohepatitis …
global prevalence. Its progressive subtype, metabolic dysfunction-associated steatohepatitis …
Identification of common signature genes and pathways underlying the pathogenesis association between nonalcoholic fatty liver disease and heart failure
G Li, Z Lu, Z Chen - Frontiers in Immunology, 2024 - frontiersin.org
Background Non-alcoholic fatty liver disease (NAFLD) and heart failure (HF) are related
conditions with an increasing incidence. However, the mechanism underlying their …
conditions with an increasing incidence. However, the mechanism underlying their …